Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET.
Zader JA, Jörres RA, Mayer I, Alter P, Bals R, Watz H, Mertsch P, Rabe KF, Herth F, Trudzinski FC, Welte T, Kauczor HU, Behr J, Walter J, Vogelmeier CF, Kahnert K.
Zader JA, et al. Among authors: vogelmeier cf.
BMC Pulm Med. 2024 Mar 1;24(1):103. doi: 10.1186/s12890-024-02902-4.
BMC Pulm Med. 2024.
PMID: 38424530
Free PMC article.